Citation Impact
Citing Papers
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Cancer in inflammatory bowel disease
2008
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
2009
Extraintestinal manifestations of inflammatory bowel disease
2002
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County
2004
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis
2010
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
2005
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Type I interferons in infectious disease
2015 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Ulcerative colitis
2002
Glucocorticoid‐induced tumour necrosis factor receptor family‐related receptor signalling exacerbates hapten‐induced colitis by CD4+ T cells
2006 StandoutNobel
The AP-1 transcriptional complex: Local switch or remote command?
2019
Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease
2006
Inflammatory bowel disease is not associated with an increased risk of lymphoma
2001
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Assessment of Histologic Disease Activity in Crohnʼs Disease
2014
P-selectin
2007
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Hepatosplenic T-Gammadelta Lymphoma in a Patient with Crohn's Disease Treated with Azathioprine
2003
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Ulcerative colitis
2016 Standout
Gut flora in health and disease
2003 Standout
Oxidative Stress in Cancer
2020 Standout
Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies
2002
The European Panel on the Appropriateness of Gastrointestinal Endoscopy guidelines colonoscopy in an open‐access endoscopy unit: a prospective study
2005
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
The DREAM complex: master coordinator of cell cycle-dependent gene expression
2013
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
2005
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?
2007
Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals
2010 Standout
Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases
2014
Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review
2011 Standout
Management of Crohn's Disease in Adults
2009 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Epstein-Barr virus–positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
2002
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature
2008
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Helicobacter pyloriInduces Interleukin-8 Secretion by Toll-Like Receptor 2- and Toll-Like Receptor 5-Dependent and -Independent Pathways
2005
Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis
2016
Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease
2007
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
2001
Quality indicators for colonoscopy
2014 Standout
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Type I IFNs Downregulate Myeloid Cell IFN-γ Receptor by Inducing Recruitment of an Early Growth Response 3/NGFI-A Binding Protein 1 Complex That Silences ifngr1 Transcription
2013
Works of Yeng Ang being referenced
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
2000
The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
2012
Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma
2017
The yield of colonoscopy in average-risk patients with non-specific colonic symptoms
2002
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
2000
Helicobacter pyloriActivates the Early Growth Response 1 Protein in Gastric Epithelial Cells
2004